A study among doctors towards antihypersensitive prescription practice in chennai city
Keywords:
Hypersensitive Drugs, Market, Pharmaceutical, Forecast.Abstract
The Global Anti-Hypertensive Market is set to show flat growth in the near future. In 2009, the global anti-hypertensive
market was estimated to be worth $27.2 billion, representing a Compound Annual Growth Rate (CAGR) of 5.0% between
2002 and 2009. The market is forecast to reach $30 billion by 2016, indicating a CAGR of 1.5% between 2009 and 2016.
The current anti-hypertensive pipeline does offer some promising novel products, such as Actos, LCZ6 Macitentan and
Riociguat, indicated for the treatment of hypertension and PAH. However, the revenues generated from these products are
not expected to completely make up for the revenue losses due to patent expires. Thus, the overall global anti-hypertensive
market is expected to show flat growth during the forecast period. Large pharmaceutical companies that have established
themselves in the cardiovascular arena are steering away from development in the antihypertensive market.
